HBV基因型与慢性乙型肝炎疾病谱的关系  

A Study on the Relationship between HBV Genotype and Outcome of Hepatitis B Virus Infection

作　　者：阎丽[1] 侯金林[1] 孙剑[1] 林裕龙[1] 

机构地区：[1]第一军医大学南方医院感染科

出　　处：《中国医师杂志》2004年第10期1347-1348,共2页Journal of Chinese Physician

基　　金：973计划基金;国家自然科学基金联合资助 (G1 9990 541 0 5和 39630 2 80 )

摘　　要：目的　探讨乙型肝炎病毒 (HBV)基因型与慢性乙型肝炎疾病谱相关性。方法　用S基因聚合酶链式反应 -限制片段长度多态性 (PCR -RFLP)的基因型分型方法对广东地区HBV感染者中无症状携带者 (AsC)组 80例和肝硬化组 (LC) 12 0例血清标本分型 ,比较两组基因型分布的异同。结果　基因型在AsC组分布 :B型 45 0 % ( 3 7/ 80 ) ;C型 3 3 75 % ( 2 6/ 80 ) ;D基因型 2 1 2 5 % ( 17/80 ) ;LC组HBV基因型分布B型 3 2 5 % ( 3 9/ 12 0 ) ;C型 65 8% ( 79/ 12 0 ) ;D基因型 1 6% ( 2 / 12 0 )。广州地区未发现A、E和F基因型 ,基因型在两组中的分布均与e抗原状态无显著性差异 (P >0 0 5 ) ;ASC与LC组两组间基因型的分布有显著性差异 ( χ2 =3 1 92 4,P=0 0 0 0 )。结论　可初步认为广东地区HBV感染者以B和C型为优势基因型 ,AsC组中以B型为优势基因型 ,感染HBVD基因型病情轻 ,感染HBVC基因型病情更易于加重。Objective To explore the relationship between hepatitis B virus (HBV) genotype and outcome of HBV infection. Methods PCR amplification of HBV small S gene in combination with a restriction fragment length polymorphism (RFLP) analysis was applied to identify HBV genotype in the serum samples of 80 asymptomatic HBV carriers (AsC group) and 120 liver cirrhosis patients with HBV infection (LC group) in Gangdong province of China. Results The frequency of HBV genotypes B, C and D in AsC group was 45% (37/80), 33.75%(26/80) and 21.25%(17/80)respectively, and that of HBV genotypes B, C and D in LC group was 32.5%(39/120), 65.8%(79/120) and 1.6%(2/120) respectively. There is no HBV genotypes A, E and F in this series. The distribution of HBV genotypes in the two groups was not significant correlation with the state of HBeAg. There was a significant difference in the distribution of HBV genotypes between the two groups (P<0.01). Conclusion HBV genotypes B and C were the major genotypes of HBV infectious population in Guangdong province. HBV genotype C was associated with the development of severe liver diseases, while the patients with genotype D HBV infection had a relatively good prognosis.

关 键 词：HBV基因型 ASC 疾病谱 慢性乙型肝炎 LC 病情 HBV感染 优势 结论 广东地区 

分 类 号：R512.62[医药卫生—内科学]